{
  "metadata": {
    "graph_path": "./logic_graph.png",
    "num_solutions": 11,
    "family_stats": {
      "1": {
        "core": 1,
        "branch": 4
      },
      "2": {
        "core": 1,
        "branch": 1
      },
      "3": {
        "core": 1,
        "branch": 3
      }
    }
  },
  "knowledge_base": {
    "rules": [
      {
        "id": "Rule1",
        "formal": "(A1 ∨ G)",
        "prover9_expression": "(administers(trial_coordinator, placebo) | successful(trial))",
        "natural": "Either the trial coordinator administers the placebo or the trial is successful."
      },
      {
        "id": "Rule2",
        "formal": "(A10 → (A7 → G))",
        "prover9_expression": "(reports_adverse_event(patient) -> (passes_efficacy_check(drug) -> successful(trial)))",
        "natural": "If the patient reports an adverse event, then, provided that the drug passes the efficacy check, the trial is successful."
      },
      {
        "id": "Rule3",
        "formal": "(A11 → (A9 ∨ A10))",
        "prover9_expression": "(is_enrolled(patient, trial) -> (withdraws_from_trial(patient) | reports_adverse_event(patient)))",
        "natural": "If the patient is enrolled in the trial, then either the patient withdraws from the trial or the patient reports an adverse event."
      },
      {
        "id": "Rule4",
        "formal": "(A13 → A12)",
        "prover9_expression": "(receives_medical_monitoring(patient) -> receives_compensation(patient))",
        "natural": "Under the condition that the patient receives medical monitoring, the patient receives compensation."
      },
      {
        "id": "Rule5",
        "formal": "(A15 → A16)",
        "prover9_expression": "(achieves_primary_endpoint(trial) -> achieves_secondary_endpoint(trial))",
        "natural": "In the event that the trial achieves its primary endpoint, the trial achieves its secondary endpoint."
      },
      {
        "id": "Rule6",
        "formal": "(A17 → (A16 → A14))",
        "prover9_expression": "(publishes_results(researcher) -> (achieves_secondary_endpoint(trial) -> shows_improvement(patient)))",
        "natural": "If the researcher publishes the results, then, provided that the trial achieves its secondary endpoint, the patient shows improvement."
      },
      {
        "id": "Rule7",
        "formal": "(A18 → (A16 → A14))",
        "prover9_expression": "(presents_at_conference(researcher) -> (achieves_secondary_endpoint(trial) -> shows_improvement(patient)))",
        "natural": "Whenever the researcher presents at a conference, then, under the condition that the trial achieves its secondary endpoint, the patient shows improvement."
      },
      {
        "id": "Rule8",
        "formal": "(A2 → ¬A1)",
        "prover9_expression": "(administers(trial_coordinator, experimental_drug) -> -administers(trial_coordinator, placebo))",
        "natural": "Provided that the trial coordinator administers the experimental drug, it is not the case that the trial coordinator administers the placebo."
      },
      {
        "id": "Rule9",
        "formal": "(A20 → (A19 ∨ (A17 ∨ A18)))",
        "prover9_expression": "(licenses_technology(company) -> (files_patent(company) | (publishes_results(researcher) | presents_at_conference(researcher))))",
        "natural": "If the company licenses the technology, then the company files a patent or the researcher publishes the results or the researcher presents at a conference."
      },
      {
        "id": "Rule10",
        "formal": "(A20 ∨ A21)",
        "prover9_expression": "(licenses_technology(company) | acquires_company(pharma_giant))",
        "natural": "Either the company licenses the technology or the pharma giant acquires the company."
      },
      {
        "id": "Rule11",
        "formal": "(A21 → A22)",
        "prover9_expression": "(acquires_company(pharma_giant) -> markets_drug(pharma_giant))",
        "natural": "Provided that the pharma giant acquires the company, the pharma giant markets the drug."
      },
      {
        "id": "Rule12",
        "formal": "(A22 → (A19 ∨ (A17 ∨ A18)))",
        "prover9_expression": "(markets_drug(pharma_giant) -> (files_patent(company) | (publishes_results(researcher) | presents_at_conference(researcher))))",
        "natural": "Whenever the pharma giant markets the drug, the company files a patent or the researcher publishes the results or the researcher presents at a conference."
      },
      {
        "id": "Rule13",
        "formal": "(A23 → (¬A2 → A3))",
        "prover9_expression": "(halts_trial(ethics_board) -> (-administers(trial_coordinator, experimental_drug) -> experiences_side_effect(patient)))",
        "natural": "If the ethics board halts the trial, then, given that the trial coordinator does not administer the experimental drug, the patient experiences a side effect."
      },
      {
        "id": "Rule14",
        "formal": "(A23 ∨ A24)",
        "prover9_expression": "(halts_trial(ethics_board) | halts_trial(data_safety_monitor))",
        "natural": "Either the ethics board halts the trial or the data safety monitor halts the trial."
      },
      {
        "id": "Rule15",
        "formal": "(A25 ∨ (A24 → (¬A2 → A3)))",
        "prover9_expression": "(violates_protocol(staff_member) | (halts_trial(data_safety_monitor) -> (-administers(trial_coordinator, experimental_drug) -> experiences_side_effect(patient))))",
        "natural": "The staff member violates the protocol or, if the data safety monitor halts the trial, then, given that the trial coordinator does not administer the experimental drug, the patient experiences a side effect."
      },
      {
        "id": "Rule16",
        "formal": "(A28 → (¬A2 → A3))",
        "prover9_expression": "(recommends_approval(advisory_committee) -> (-administers(trial_coordinator, experimental_drug) -> experiences_side_effect(patient)))",
        "natural": "Provided that the advisory committee recommends approval, then, whenever the trial coordinator does not administer the experimental drug, the patient experiences a side effect."
      },
      {
        "id": "Rule17",
        "formal": "(A28 ∨ A29)",
        "prover9_expression": "(recommends_approval(advisory_committee) | recommends_approval(regulatory_consultant))",
        "natural": "Either the advisory committee recommends approval or the regulatory consultant recommends approval."
      },
      {
        "id": "Rule18",
        "formal": "(A30 → (A29 → (¬A2 → A3)))",
        "prover9_expression": "(submits_application(company) -> (recommends_approval(regulatory_consultant) -> (-administers(trial_coordinator, experimental_drug) -> experiences_side_effect(patient))))",
        "natural": "If the company submits an application, then, provided that the regulatory consultant recommends approval, whenever the trial coordinator does not administer the experimental drug, the patient experiences a side effect."
      },
      {
        "id": "Rule19",
        "formal": "(A30 ∨ A31)",
        "prover9_expression": "(submits_application(company) | submits_application(researcher))",
        "natural": "The company submits an application or the researcher submits an application."
      },
      {
        "id": "Rule20",
        "formal": "(A31 → (A29 → (¬A2 → A3)))",
        "prover9_expression": "(submits_application(researcher) -> (recommends_approval(regulatory_consultant) -> (-administers(trial_coordinator, experimental_drug) -> experiences_side_effect(patient))))",
        "natural": "Whenever the researcher submits an application, then, given that the regulatory consultant recommends approval, under the condition that the trial coordinator does not administer the experimental drug, the patient experiences a side effect."
      },
      {
        "id": "Rule21",
        "formal": "(A34 → A33)",
        "prover9_expression": "(conducts_analysis(biostatistician) -> shows_statistical_significance(trial))",
        "natural": "Provided that the biostatistician conducts an analysis, the trial shows statistical significance."
      },
      {
        "id": "Rule22",
        "formal": "(A34 ∨ A35)",
        "prover9_expression": "(conducts_analysis(biostatistician) | detects_anomaly(data_auditor))",
        "natural": "The biostatistician conducts an analysis or the data auditor detects an anomaly."
      },
      {
        "id": "Rule23",
        "formal": "(A38 → A37)",
        "prover9_expression": "(tests_purity(lab_technician) -> passes_quality_control(drug))",
        "natural": "Under the condition that the lab technician tests purity, the drug passes quality control."
      },
      {
        "id": "Rule24",
        "formal": "(A38 ∨ A39)",
        "prover9_expression": "(tests_purity(lab_technician) | tests_stability(lab_technician))",
        "natural": "The lab technician tests purity or the lab technician tests stability."
      },
      {
        "id": "Rule25",
        "formal": "(A39 → A40)",
        "prover9_expression": "(tests_stability(lab_technician) -> confirms_specifications(lab_technician))",
        "natural": "Whenever the lab technician tests stability, the lab technician confirms specifications."
      },
      {
        "id": "Rule26",
        "formal": "(A4 → A32)",
        "prover9_expression": "(receives_approval(fda, trial) -> meets_endpoint_criteria(trial))",
        "natural": "If the FDA receives approval for the trial, then the trial meets endpoint criteria."
      },
      {
        "id": "Rule27",
        "formal": "(A4 → A5)",
        "prover9_expression": "(receives_approval(fda, trial) -> receives_funding(trial))",
        "natural": "Given that the FDA receives approval for the trial, the trial receives funding."
      },
      {
        "id": "Rule28",
        "formal": "(A4 → ¬A5)",
        "prover9_expression": "(receives_approval(fda, trial) -> -receives_funding(trial))",
        "natural": "In the event that the FDA receives approval for the trial, the trial does not receive funding."
      },
      {
        "id": "Rule29",
        "formal": "(A4 ∨ (¬A2 → A3))",
        "prover9_expression": "(receives_approval(fda, trial) | (-administers(trial_coordinator, experimental_drug) -> experiences_side_effect(patient)))",
        "natural": "The FDA receives approval for the trial or, provided that the trial coordinator does not administer the experimental drug, the patient experiences a side effect."
      },
      {
        "id": "Rule30",
        "formal": "(A40 → ¬A4)",
        "prover9_expression": "(confirms_specifications(lab_technician) -> -receives_approval(fda, trial))",
        "natural": "If the lab technician confirms specifications, then the FDA does not receive approval for the trial."
      },
      {
        "id": "Rule31",
        "formal": "(A42 ∨ A43)",
        "prover9_expression": "(reports_misconduct(whistleblower) | reports_misconduct(monitor))",
        "natural": "Either the whistleblower reports misconduct or the monitor reports misconduct."
      },
      {
        "id": "Rule32",
        "formal": "(A43 → ¬A41)",
        "prover9_expression": "(reports_misconduct(monitor) -> -drops_out(patient))",
        "natural": "Under the condition that the monitor reports misconduct, the patient does not drop out."
      },
      {
        "id": "Rule33",
        "formal": "(A44 → (A42 → ¬A41))",
        "prover9_expression": "(initiates_audit(regulator) -> (reports_misconduct(whistleblower) -> -drops_out(patient)))",
        "natural": "If the regulator initiates an audit, then, given that the whistleblower reports misconduct, the patient does not drop out."
      },
      {
        "id": "Rule34",
        "formal": "(A44 ∨ A45)",
        "prover9_expression": "(initiates_audit(regulator) | initiates_audit(sponsor))",
        "natural": "The regulator initiates an audit or the sponsor initiates an audit."
      },
      {
        "id": "Rule35",
        "formal": "(A45 → (A42 → ¬A41))",
        "prover9_expression": "(initiates_audit(sponsor) -> (reports_misconduct(whistleblower) -> -drops_out(patient)))",
        "natural": "Whenever the sponsor initiates an audit, then, provided that the whistleblower reports misconduct, the patient does not drop out."
      },
      {
        "id": "Rule36",
        "formal": "(A46 → A19)",
        "prover9_expression": "(seeks_partnership(company) -> files_patent(company))",
        "natural": "In the event that the company seeks partnership, the company files a patent."
      },
      {
        "id": "Rule37",
        "formal": "(A47 → (A17 ∨ A18))",
        "prover9_expression": "(seeks_collaboration(researcher) -> (publishes_results(researcher) | presents_at_conference(researcher)))",
        "natural": "Provided that the researcher seeks collaboration, the researcher publishes the results or the researcher presents at a conference."
      },
      {
        "id": "Rule38",
        "formal": "(A48 → (A46 ∨ A47))",
        "prover9_expression": "(analyzes_data(data_scientist) -> (seeks_partnership(company) | seeks_collaboration(researcher)))",
        "natural": "If the data scientist analyzes data, then the company seeks partnership or the researcher seeks collaboration."
      },
      {
        "id": "Rule39",
        "formal": "(A49 → A50)",
        "prover9_expression": "(launches_drug(company) -> generates_revenue(drug))",
        "natural": "Under the condition that the company launches the drug, the drug generates revenue."
      },
      {
        "id": "Rule40",
        "formal": "(A49 ∨ (A21 → (A19 ∨ (A17 ∨ A18))))",
        "prover9_expression": "(launches_drug(company) | (acquires_company(pharma_giant) -> (files_patent(company) | (publishes_results(researcher) | presents_at_conference(researcher)))))",
        "natural": "The company launches the drug or, if the pharma giant acquires the company, then the company files a patent or the researcher publishes the results or the researcher presents at a conference."
      },
      {
        "id": "Rule41",
        "formal": "(A51 → ¬A50)",
        "prover9_expression": "(recalls_drug(manufacturer) -> -generates_revenue(drug))",
        "natural": "Provided that the manufacturer recalls the drug, the drug does not generate revenue."
      },
      {
        "id": "Rule42",
        "formal": "(A51 ∨ A52)",
        "prover9_expression": "(recalls_drug(manufacturer) | recalls_drug(regulator))",
        "natural": "Either the manufacturer recalls the drug or the regulator recalls the drug."
      },
      {
        "id": "Rule43",
        "formal": "(A52 → ¬A50)",
        "prover9_expression": "(recalls_drug(regulator) -> -generates_revenue(drug))",
        "natural": "Whenever the regulator recalls the drug, the drug does not generate revenue."
      },
      {
        "id": "Rule44",
        "formal": "(A54 → ¬A53)",
        "prover9_expression": "(shows_deterioration(patient) -> -shows_no_change(patient))",
        "natural": "If the patient shows deterioration, then the patient does not show no change."
      },
      {
        "id": "Rule45",
        "formal": "(A6 → G)",
        "prover9_expression": "(passes_safety_check(drug) -> successful(trial))",
        "natural": "Given that the drug passes the safety check, the trial is successful."
      },
      {
        "id": "Rule46",
        "formal": "(A6 ∨ A7)",
        "prover9_expression": "(passes_safety_check(drug) | passes_efficacy_check(drug))",
        "natural": "Either the drug passes the safety check or the drug passes the efficacy check."
      },
      {
        "id": "Rule47",
        "formal": "(A9 → A8)",
        "prover9_expression": "(withdraws_from_trial(patient) -> completes_trial(patient))",
        "natural": "If the patient withdraws from the trial, then the patient completes the trial."
      },
      {
        "id": "Rule48",
        "formal": "(¬(A25 → A26) → A27)",
        "prover9_expression": "(-(violates_protocol(staff_member) -> receives_warning(staff_member)) -> faces_termination(staff_member))",
        "natural": "If it is not the case that, if the staff member violates the protocol then the staff member receives a warning, then the staff member faces termination."
      },
      {
        "id": "Rule49",
        "formal": "(¬(A35 → ¬A32) → A36)",
        "prover9_expression": "(-(detects_anomaly(data_auditor) -> -meets_endpoint_criteria(trial)) -> triggers_investigation(data_auditor))",
        "natural": "Provided that it is not the case that, if the data auditor detects an anomaly then the trial does not meet endpoint criteria, the data auditor triggers an investigation."
      },
      {
        "id": "Rule50",
        "formal": "(¬(A9 ∨ A10) → A41)",
        "prover9_expression": "(-(withdraws_from_trial(patient) | reports_adverse_event(patient)) -> drops_out(patient))",
        "natural": "If it is not the case that the patient withdraws from the trial or the patient reports an adverse event, then the patient drops out."
      },
      {
        "id": "Rule51",
        "formal": "(¬(¬G → A14) → A53)",
        "prover9_expression": "(-(-successful(trial) -> shows_improvement(patient)) -> shows_no_change(patient))",
        "natural": "Given that it is not the case that, if the trial is not successful then the patient shows improvement, the patient shows no change."
      },
      {
        "id": "Rule52",
        "formal": "(¬(¬G → A14) → A54)",
        "prover9_expression": "(-(-successful(trial) -> shows_improvement(patient)) -> shows_deterioration(patient))",
        "natural": "Under the condition that it is not the case that, if the trial is not successful then the patient shows improvement, the patient shows deterioration."
      },
      {
        "id": "Rule53",
        "formal": "(¬A11 → A13)",
        "prover9_expression": "(-is_enrolled(patient, trial) -> receives_medical_monitoring(patient))",
        "natural": "Provided that the patient is not enrolled in the trial, the patient receives medical monitoring."
      },
      {
        "id": "Rule54",
        "formal": "(¬A2 → ¬A3)",
        "prover9_expression": "(-administers(trial_coordinator, experimental_drug) -> -experiences_side_effect(patient))",
        "natural": "If the trial coordinator does not administer the experimental drug, then the patient does not experience a side effect."
      },
      {
        "id": "Rule55",
        "formal": "(¬G → A15)",
        "prover9_expression": "(-successful(trial) -> achieves_primary_endpoint(trial))",
        "natural": "Under the condition that the trial is not successful, the trial achieves its primary endpoint."
      }
    ],
    "facts": [
      {
        "id": "Fact1",
        "formal": "A48",
        "prover9_expression": "analyzes_data(data_scientist)",
        "natural": "The data scientist analyzes data."
      },
      {
        "id": "Fact2",
        "formal": "¬A12",
        "prover9_expression": "-receives_compensation(patient)",
        "natural": "The patient does not receive compensation."
      },
      {
        "id": "Fact3",
        "formal": "¬A14",
        "prover9_expression": "-shows_improvement(patient)",
        "natural": "The patient does not show improvement."
      },
      {
        "id": "Fact4",
        "formal": "¬A19",
        "prover9_expression": "-files_patent(company)",
        "natural": "The company does not file a patent."
      },
      {
        "id": "Fact5",
        "formal": "¬A26",
        "prover9_expression": "-receives_warning(staff_member)",
        "natural": "The staff member does not receive a warning."
      },
      {
        "id": "Fact6",
        "formal": "¬A27",
        "prover9_expression": "-faces_termination(staff_member)",
        "natural": "The staff member does not face termination."
      },
      {
        "id": "Fact7",
        "formal": "¬A33",
        "prover9_expression": "-shows_statistical_significance(trial)",
        "natural": "The trial does not show statistical significance."
      },
      {
        "id": "Fact8",
        "formal": "¬A36",
        "prover9_expression": "-triggers_investigation(data_auditor)",
        "natural": "The data auditor does not trigger an investigation."
      },
      {
        "id": "Fact9",
        "formal": "¬A37",
        "prover9_expression": "-passes_quality_control(drug)",
        "natural": "The drug does not pass quality control."
      },
      {
        "id": "Fact10",
        "formal": "¬A8",
        "prover9_expression": "-completes_trial(patient)",
        "natural": "The patient does not complete the trial."
      }
    ]
  },
  "target": {
    "formal": "G",
    "prover9": "G",
    "prover9_expression": "successful(trial)",
    "natural": "The trial is successful."
  },
  "solutions": [
    {
      "id": 1,
      "family_id": 1,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "RAA",
          "premises_used": [
            "(A4 -> A5)",
            "(A4 -> -A5)"
          ],
          "conclusion": "-A4",
          "natural": "The FDA does not receive approval for the trial."
        },
        {
          "step_number": 2,
          "rule_applied": "DS",
          "premises_used": [
            "(A4 | (-A2 -> A3))",
            "-A4"
          ],
          "conclusion": "(-A2 -> A3)",
          "natural": "In the event that the trial coordinator does not administer the experimental drug, the patient experiences a side effect."
        },
        {
          "step_number": 3,
          "rule_applied": "RAA",
          "premises_used": [
            "(-A2 -> A3)",
            "(-A2 -> -A3)"
          ],
          "conclusion": "A2",
          "natural": "The trial coordinator administers the experimental drug."
        },
        {
          "step_number": 4,
          "rule_applied": "MP",
          "premises_used": [
            "(A2 -> -A1)",
            "A2"
          ],
          "conclusion": "-A1",
          "natural": "It is not the case that the trial coordinator administers the placebo."
        },
        {
          "step_number": 5,
          "rule_applied": "DS",
          "premises_used": [
            "(A1 | G)",
            "-A1"
          ],
          "conclusion": "G",
          "natural": "The trial is successful."
        }
      ]
    },
    {
      "id": 2,
      "family_id": 2,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            "(-A11 -> A13)",
            "(A13 -> A12)"
          ],
          "conclusion": "(-A11 -> A12)",
          "natural": "If the patient is not enrolled in the trial, then the patient receives compensation."
        },
        {
          "step_number": 2,
          "rule_applied": "MT",
          "premises_used": [
            "(-A11 -> A12)",
            "-A12"
          ],
          "conclusion": "A11",
          "natural": "The patient is enrolled in the trial."
        },
        {
          "step_number": 3,
          "rule_applied": "MP",
          "premises_used": [
            "(A11 -> (A9 | A10))",
            "A11"
          ],
          "conclusion": "(A9 | A10)",
          "natural": "Either the patient withdraws from the trial or the patient reports an adverse event."
        },
        {
          "step_number": 4,
          "rule_applied": "CD",
          "premises_used": [
            "(A9 -> A8)",
            "(A10 -> (A7 -> G))",
            "(A9 | A10)"
          ],
          "conclusion": "(A8 | (A7 -> G))",
          "natural": "The patient completes the trial or, provided that the drug passes the efficacy check, the trial is successful."
        },
        {
          "step_number": 5,
          "rule_applied": "DS",
          "premises_used": [
            "(A8 | (A7 -> G))",
            "-A8"
          ],
          "conclusion": "(A7 -> G)",
          "natural": "Under the condition that the drug passes the efficacy check, the trial is successful."
        },
        {
          "step_number": 6,
          "rule_applied": "DE",
          "premises_used": [
            "(A6 | A7)",
            "(A6 -> G)",
            "(A7 -> G)"
          ],
          "conclusion": "G",
          "natural": "The trial is successful."
        }
      ]
    },
    {
      "id": 3,
      "family_id": 3,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            "(A21 -> A22)",
            "(A22 -> (A19 | (A17 | A18)))"
          ],
          "conclusion": "(A21 -> (A19 | (A17 | A18)))",
          "natural": "In the event that the pharma giant acquires the company, the company files a patent or the researcher publishes the results or the researcher presents at a conference."
        },
        {
          "step_number": 2,
          "rule_applied": "DE",
          "premises_used": [
            "(A20 | A21)",
            "(A20 -> (A19 | (A17 | A18)))",
            "(A21 -> (A19 | (A17 | A18)))"
          ],
          "conclusion": "(A19 | (A17 | A18))",
          "natural": "The company files a patent, or the researcher publishes the results, or the researcher presents at a conference."
        },
        {
          "step_number": 3,
          "rule_applied": "DS",
          "premises_used": [
            "(A19 | (A17 | A18))",
            "-A19"
          ],
          "conclusion": "(A17 | A18)",
          "natural": "The researcher publishes the results or the researcher presents at a conference."
        },
        {
          "step_number": 4,
          "rule_applied": "DE",
          "premises_used": [
            "(A17 | A18)",
            "(A17 -> (A16 -> A14))",
            "(A18 -> (A16 -> A14))"
          ],
          "conclusion": "(A16 -> A14)",
          "natural": "Given that the trial achieves its secondary endpoint, the patient shows improvement."
        },
        {
          "step_number": 5,
          "rule_applied": "HS",
          "premises_used": [
            "(A15 -> A16)",
            "(A16 -> A14)"
          ],
          "conclusion": "(A15 -> A14)",
          "natural": "Whenever the trial achieves its primary endpoint, the patient shows improvement."
        },
        {
          "step_number": 6,
          "rule_applied": "HS",
          "premises_used": [
            "(-G -> A15)",
            "(A15 -> A14)"
          ],
          "conclusion": "(-G -> A14)",
          "natural": "Given that the trial is not successful, the patient shows improvement."
        },
        {
          "step_number": 7,
          "rule_applied": "MT",
          "premises_used": [
            "(-G -> A14)",
            "-A14"
          ],
          "conclusion": "G",
          "natural": "The trial is successful."
        }
      ]
    },
    {
      "id": 4,
      "family_id": 1,
      "path_type": "branch",
      "branch_from": 1,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MT",
          "premises_used": [
            "(-(A25 -> A26) -> A27)",
            "-A27"
          ],
          "conclusion": "(A25 -> A26)",
          "natural": "If the staff member violates the protocol, then the staff member receives a warning."
        },
        {
          "step_number": 2,
          "rule_applied": "MT",
          "premises_used": [
            "(A25 -> A26)",
            "-A26"
          ],
          "conclusion": "-A25",
          "natural": "The staff member does not violate the protocol."
        },
        {
          "step_number": 3,
          "rule_applied": "DS",
          "premises_used": [
            "(A25 | (A24 -> (-A2 -> A3)))",
            "-A25"
          ],
          "conclusion": "(A24 -> (-A2 -> A3))",
          "natural": "Under the condition that the data safety monitor halts the trial, then, provided that the trial coordinator does not administer the experimental drug, the patient experiences a side effect."
        },
        {
          "step_number": 4,
          "rule_applied": "DE",
          "premises_used": [
            "(A23 | A24)",
            "(A23 -> (-A2 -> A3))",
            "(A24 -> (-A2 -> A3))"
          ],
          "conclusion": "(-A2 -> A3)",
          "natural": "In the event that the trial coordinator does not administer the experimental drug, the patient experiences a side effect."
        },
        {
          "step_number": 5,
          "rule_applied": "RAA",
          "premises_used": [
            "(-A2 -> A3)",
            "(-A2 -> -A3)"
          ],
          "conclusion": "A2",
          "natural": "The trial coordinator administers the experimental drug."
        },
        {
          "step_number": 6,
          "rule_applied": "MP",
          "premises_used": [
            "(A2 -> -A1)",
            "A2"
          ],
          "conclusion": "-A1",
          "natural": "It is not the case that the trial coordinator administers the placebo."
        },
        {
          "step_number": 7,
          "rule_applied": "DS",
          "premises_used": [
            "(A1 | G)",
            "-A1"
          ],
          "conclusion": "G",
          "natural": "The trial is successful."
        }
      ]
    },
    {
      "id": 5,
      "family_id": 1,
      "path_type": "branch",
      "branch_from": 1,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DE",
          "premises_used": [
            "(A30 | A31)",
            "(A30 -> (A29 -> (-A2 -> A3)))",
            "(A31 -> (A29 -> (-A2 -> A3)))"
          ],
          "conclusion": "(A29 -> (-A2 -> A3))",
          "natural": "In the event that the regulatory consultant recommends approval, then, under the condition that the trial coordinator does not administer the experimental drug, the patient experiences a side effect."
        },
        {
          "step_number": 2,
          "rule_applied": "DE",
          "premises_used": [
            "(A28 | A29)",
            "(A28 -> (-A2 -> A3))",
            "(A29 -> (-A2 -> A3))"
          ],
          "conclusion": "(-A2 -> A3)",
          "natural": "In the event that the trial coordinator does not administer the experimental drug, the patient experiences a side effect."
        },
        {
          "step_number": 3,
          "rule_applied": "RAA",
          "premises_used": [
            "(-A2 -> A3)",
            "(-A2 -> -A3)"
          ],
          "conclusion": "A2",
          "natural": "The trial coordinator administers the experimental drug."
        },
        {
          "step_number": 4,
          "rule_applied": "MP",
          "premises_used": [
            "(A2 -> -A1)",
            "A2"
          ],
          "conclusion": "-A1",
          "natural": "It is not the case that the trial coordinator administers the placebo."
        },
        {
          "step_number": 5,
          "rule_applied": "DS",
          "premises_used": [
            "(A1 | G)",
            "-A1"
          ],
          "conclusion": "G",
          "natural": "The trial is successful."
        }
      ]
    },
    {
      "id": 6,
      "family_id": 1,
      "path_type": "branch",
      "branch_from": 0,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MT",
          "premises_used": [
            "(-(A35 -> -A32) -> A36)",
            "-A36"
          ],
          "conclusion": "(A35 -> -A32)",
          "natural": "If the data auditor detects an anomaly, then the trial does not meet endpoint criteria."
        },
        {
          "step_number": 2,
          "rule_applied": "CD",
          "premises_used": [
            "(A34 -> A33)",
            "(A35 -> -A32)",
            "(A34 | A35)"
          ],
          "conclusion": "(A33 | -A32)",
          "natural": "Either the trial shows statistical significance or the trial does not meet endpoint criteria."
        },
        {
          "step_number": 3,
          "rule_applied": "DS",
          "premises_used": [
            "(A33 | -A32)",
            "-A33"
          ],
          "conclusion": "-A32",
          "natural": "The trial does not meet endpoint criteria."
        },
        {
          "step_number": 4,
          "rule_applied": "MT",
          "premises_used": [
            "(A4 -> A32)",
            "-A32"
          ],
          "conclusion": "-A4",
          "natural": "The FDA does not receive approval for the trial."
        },
        {
          "step_number": 5,
          "rule_applied": "DS",
          "premises_used": [
            "(A4 | (-A2 -> A3))",
            "-A4"
          ],
          "conclusion": "(-A2 -> A3)",
          "natural": "In the event that the trial coordinator does not administer the experimental drug, the patient experiences a side effect."
        },
        {
          "step_number": 6,
          "rule_applied": "RAA",
          "premises_used": [
            "(-A2 -> A3)",
            "(-A2 -> -A3)"
          ],
          "conclusion": "A2",
          "natural": "The trial coordinator administers the experimental drug."
        },
        {
          "step_number": 7,
          "rule_applied": "MP",
          "premises_used": [
            "(A2 -> -A1)",
            "A2"
          ],
          "conclusion": "-A1",
          "natural": "It is not the case that the trial coordinator administers the placebo."
        },
        {
          "step_number": 8,
          "rule_applied": "DS",
          "premises_used": [
            "(A1 | G)",
            "-A1"
          ],
          "conclusion": "G",
          "natural": "The trial is successful."
        }
      ]
    },
    {
      "id": 7,
      "family_id": 1,
      "path_type": "branch",
      "branch_from": 0,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            "(A39 -> A40)",
            "(A40 -> -A4)"
          ],
          "conclusion": "(A39 -> -A4)",
          "natural": "Provided that the lab technician tests stability, the FDA does not receive approval for the trial."
        },
        {
          "step_number": 2,
          "rule_applied": "CD",
          "premises_used": [
            "(A38 -> A37)",
            "(A39 -> -A4)",
            "(A38 | A39)"
          ],
          "conclusion": "(A37 | -A4)",
          "natural": "Either the drug passes quality control or the FDA does not receive approval for the trial."
        },
        {
          "step_number": 3,
          "rule_applied": "DS",
          "premises_used": [
            "(A37 | -A4)",
            "-A37"
          ],
          "conclusion": "-A4",
          "natural": "The FDA does not receive approval for the trial."
        },
        {
          "step_number": 4,
          "rule_applied": "DS",
          "premises_used": [
            "(A4 | (-A2 -> A3))",
            "-A4"
          ],
          "conclusion": "(-A2 -> A3)",
          "natural": "In the event that the trial coordinator does not administer the experimental drug, the patient experiences a side effect."
        },
        {
          "step_number": 5,
          "rule_applied": "RAA",
          "premises_used": [
            "(-A2 -> A3)",
            "(-A2 -> -A3)"
          ],
          "conclusion": "A2",
          "natural": "The trial coordinator administers the experimental drug."
        },
        {
          "step_number": 6,
          "rule_applied": "MP",
          "premises_used": [
            "(A2 -> -A1)",
            "A2"
          ],
          "conclusion": "-A1",
          "natural": "It is not the case that the trial coordinator administers the placebo."
        },
        {
          "step_number": 7,
          "rule_applied": "DS",
          "premises_used": [
            "(A1 | G)",
            "-A1"
          ],
          "conclusion": "G",
          "natural": "The trial is successful."
        }
      ]
    },
    {
      "id": 8,
      "family_id": 2,
      "path_type": "branch",
      "branch_from": 2,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DE",
          "premises_used": [
            "(A44 | A45)",
            "(A44 -> (A42 -> -A41))",
            "(A45 -> (A42 -> -A41))"
          ],
          "conclusion": "(A42 -> -A41)",
          "natural": "Provided that the whistleblower reports misconduct, the patient does not drop out."
        },
        {
          "step_number": 2,
          "rule_applied": "DE",
          "premises_used": [
            "(A42 | A43)",
            "(A42 -> -A41)",
            "(A43 -> -A41)"
          ],
          "conclusion": "-A41",
          "natural": "The patient does not drop out."
        },
        {
          "step_number": 3,
          "rule_applied": "MT",
          "premises_used": [
            "(-(A9 | A10) -> A41)",
            "-A41"
          ],
          "conclusion": "(A9 | A10)",
          "natural": "Either the patient withdraws from the trial or the patient reports an adverse event."
        },
        {
          "step_number": 4,
          "rule_applied": "CD",
          "premises_used": [
            "(A9 -> A8)",
            "(A10 -> (A7 -> G))",
            "(A9 | A10)"
          ],
          "conclusion": "(A8 | (A7 -> G))",
          "natural": "The patient completes the trial or, provided that the drug passes the efficacy check, the trial is successful."
        },
        {
          "step_number": 5,
          "rule_applied": "DS",
          "premises_used": [
            "(A8 | (A7 -> G))",
            "-A8"
          ],
          "conclusion": "(A7 -> G)",
          "natural": "Under the condition that the drug passes the efficacy check, the trial is successful."
        },
        {
          "step_number": 6,
          "rule_applied": "DE",
          "premises_used": [
            "(A6 | A7)",
            "(A6 -> G)",
            "(A7 -> G)"
          ],
          "conclusion": "G",
          "natural": "The trial is successful."
        }
      ]
    },
    {
      "id": 9,
      "family_id": 3,
      "path_type": "branch",
      "branch_from": 1,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MP",
          "premises_used": [
            "(A48 -> (A46 | A47))",
            "A48"
          ],
          "conclusion": "(A46 | A47)",
          "natural": "Either the company seeks partnership or the researcher seeks collaboration."
        },
        {
          "step_number": 2,
          "rule_applied": "CD",
          "premises_used": [
            "(A46 -> A19)",
            "(A47 -> (A17 | A18))",
            "(A46 | A47)"
          ],
          "conclusion": "(A19 | (A17 | A18))",
          "natural": "The company files a patent, or the researcher publishes the results, or the researcher presents at a conference."
        },
        {
          "step_number": 3,
          "rule_applied": "DS",
          "premises_used": [
            "(A19 | (A17 | A18))",
            "-A19"
          ],
          "conclusion": "(A17 | A18)",
          "natural": "The researcher publishes the results or the researcher presents at a conference."
        },
        {
          "step_number": 4,
          "rule_applied": "DE",
          "premises_used": [
            "(A17 | A18)",
            "(A17 -> (A16 -> A14))",
            "(A18 -> (A16 -> A14))"
          ],
          "conclusion": "(A16 -> A14)",
          "natural": "Given that the trial achieves its secondary endpoint, the patient shows improvement."
        },
        {
          "step_number": 5,
          "rule_applied": "HS",
          "premises_used": [
            "(A15 -> A16)",
            "(A16 -> A14)"
          ],
          "conclusion": "(A15 -> A14)",
          "natural": "Whenever the trial achieves its primary endpoint, the patient shows improvement."
        },
        {
          "step_number": 6,
          "rule_applied": "HS",
          "premises_used": [
            "(-G -> A15)",
            "(A15 -> A14)"
          ],
          "conclusion": "(-G -> A14)",
          "natural": "Given that the trial is not successful, the patient shows improvement."
        },
        {
          "step_number": 7,
          "rule_applied": "MT",
          "premises_used": [
            "(-G -> A14)",
            "-A14"
          ],
          "conclusion": "G",
          "natural": "The trial is successful."
        }
      ]
    },
    {
      "id": 10,
      "family_id": 3,
      "path_type": "branch",
      "branch_from": 0,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DE",
          "premises_used": [
            "(A51 | A52)",
            "(A51 -> -A50)",
            "(A52 -> -A50)"
          ],
          "conclusion": "-A50",
          "natural": "The drug does not generate revenue."
        },
        {
          "step_number": 2,
          "rule_applied": "MT",
          "premises_used": [
            "(A49 -> A50)",
            "-A50"
          ],
          "conclusion": "-A49",
          "natural": "The company does not launch the drug."
        },
        {
          "step_number": 3,
          "rule_applied": "DS",
          "premises_used": [
            "(A49 | (A21 -> (A19 | (A17 | A18))))",
            "-A49"
          ],
          "conclusion": "(A21 -> (A19 | (A17 | A18)))",
          "natural": "In the event that the pharma giant acquires the company, the company files a patent or the researcher publishes the results or the researcher presents at a conference."
        },
        {
          "step_number": 4,
          "rule_applied": "DE",
          "premises_used": [
            "(A20 | A21)",
            "(A20 -> (A19 | (A17 | A18)))",
            "(A21 -> (A19 | (A17 | A18)))"
          ],
          "conclusion": "(A19 | (A17 | A18))",
          "natural": "The company files a patent, or the researcher publishes the results, or the researcher presents at a conference."
        },
        {
          "step_number": 5,
          "rule_applied": "DS",
          "premises_used": [
            "(A19 | (A17 | A18))",
            "-A19"
          ],
          "conclusion": "(A17 | A18)",
          "natural": "The researcher publishes the results or the researcher presents at a conference."
        },
        {
          "step_number": 6,
          "rule_applied": "DE",
          "premises_used": [
            "(A17 | A18)",
            "(A17 -> (A16 -> A14))",
            "(A18 -> (A16 -> A14))"
          ],
          "conclusion": "(A16 -> A14)",
          "natural": "Given that the trial achieves its secondary endpoint, the patient shows improvement."
        },
        {
          "step_number": 7,
          "rule_applied": "HS",
          "premises_used": [
            "(A15 -> A16)",
            "(A16 -> A14)"
          ],
          "conclusion": "(A15 -> A14)",
          "natural": "Whenever the trial achieves its primary endpoint, the patient shows improvement."
        },
        {
          "step_number": 8,
          "rule_applied": "HS",
          "premises_used": [
            "(-G -> A15)",
            "(A15 -> A14)"
          ],
          "conclusion": "(-G -> A14)",
          "natural": "Given that the trial is not successful, the patient shows improvement."
        },
        {
          "step_number": 9,
          "rule_applied": "MT",
          "premises_used": [
            "(-G -> A14)",
            "-A14"
          ],
          "conclusion": "G",
          "natural": "The trial is successful."
        }
      ]
    },
    {
      "id": 11,
      "family_id": 3,
      "path_type": "branch",
      "branch_from": 5,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            "(-(-G -> A14) -> A54)",
            "(A54 -> -A53)"
          ],
          "conclusion": "(-(-G -> A14) -> -A53)",
          "natural": "Whenever it is not the case that, if the trial is not successful then the patient shows improvement, the patient does not show no change."
        },
        {
          "step_number": 2,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(-G -> A14) -> A53)",
            "(-(-G -> A14) -> -A53)"
          ],
          "conclusion": "(-G -> A14)",
          "natural": "Given that the trial is not successful, the patient shows improvement."
        },
        {
          "step_number": 3,
          "rule_applied": "MT",
          "premises_used": [
            "(-G -> A14)",
            "-A14"
          ],
          "conclusion": "G",
          "natural": "The trial is successful."
        }
      ]
    }
  ],
  "translations": {
    "domain_theme": "Pharmaceutical Clinical Trial",
    "atomic_facts": {
      "A1": "administers(trial_coordinator, placebo)",
      "A2": "administers(trial_coordinator, experimental_drug)",
      "A3": "experiences_side_effect(patient)",
      "A4": "receives_approval(fda, trial)",
      "A5": "receives_funding(trial)",
      "A6": "passes_safety_check(drug)",
      "A7": "passes_efficacy_check(drug)",
      "A8": "completes_trial(patient)",
      "A9": "withdraws_from_trial(patient)",
      "A10": "reports_adverse_event(patient)",
      "A11": "is_enrolled(patient, trial)",
      "A12": "receives_compensation(patient)",
      "A13": "receives_medical_monitoring(patient)",
      "A14": "shows_improvement(patient)",
      "A15": "achieves_primary_endpoint(trial)",
      "A16": "achieves_secondary_endpoint(trial)",
      "A17": "publishes_results(researcher)",
      "A18": "presents_at_conference(researcher)",
      "A19": "files_patent(company)",
      "A20": "licenses_technology(company)",
      "A21": "acquires_company(pharma_giant)",
      "A22": "markets_drug(pharma_giant)",
      "A23": "halts_trial(ethics_board)",
      "A24": "halts_trial(data_safety_monitor)",
      "A25": "violates_protocol(staff_member)",
      "A26": "receives_warning(staff_member)",
      "A27": "faces_termination(staff_member)",
      "A28": "recommends_approval(advisory_committee)",
      "A29": "recommends_approval(regulatory_consultant)",
      "A30": "submits_application(company)",
      "A31": "submits_application(researcher)",
      "A32": "meets_endpoint_criteria(trial)",
      "A33": "shows_statistical_significance(trial)",
      "A34": "conducts_analysis(biostatistician)",
      "A35": "detects_anomaly(data_auditor)",
      "A36": "triggers_investigation(data_auditor)",
      "A37": "passes_quality_control(drug)",
      "A38": "tests_purity(lab_technician)",
      "A39": "tests_stability(lab_technician)",
      "A40": "confirms_specifications(lab_technician)",
      "A41": "drops_out(patient)",
      "A42": "reports_misconduct(whistleblower)",
      "A43": "reports_misconduct(monitor)",
      "A44": "initiates_audit(regulator)",
      "A45": "initiates_audit(sponsor)",
      "A46": "seeks_partnership(company)",
      "A47": "seeks_collaboration(researcher)",
      "A48": "analyzes_data(data_scientist)",
      "A49": "launches_drug(company)",
      "A50": "generates_revenue(drug)",
      "A51": "recalls_drug(manufacturer)",
      "A52": "recalls_drug(regulator)",
      "A53": "shows_no_change(patient)",
      "A54": "shows_deterioration(patient)",
      "G": "successful(trial)"
    },
    "natural_facts": {
      "A1": "The trial coordinator administers the placebo.",
      "A2": "The trial coordinator administers the experimental drug.",
      "A3": "The patient experiences a side effect.",
      "A4": "The FDA receives approval for the trial.",
      "A5": "The trial receives funding.",
      "A6": "The drug passes the safety check.",
      "A7": "The drug passes the efficacy check.",
      "A8": "The patient completes the trial.",
      "A9": "The patient withdraws from the trial.",
      "A10": "The patient reports an adverse event.",
      "A11": "The patient is enrolled in the trial.",
      "A12": "The patient receives compensation.",
      "A13": "The patient receives medical monitoring.",
      "A14": "The patient shows improvement.",
      "A15": "The trial achieves its primary endpoint.",
      "A16": "The trial achieves its secondary endpoint.",
      "A17": "The researcher publishes the results.",
      "A18": "The researcher presents at a conference.",
      "A19": "The company files a patent.",
      "A20": "The company licenses the technology.",
      "A21": "The pharma giant acquires the company.",
      "A22": "The pharma giant markets the drug.",
      "A23": "The ethics board halts the trial.",
      "A24": "The data safety monitor halts the trial.",
      "A25": "The staff member violates the protocol.",
      "A26": "The staff member receives a warning.",
      "A27": "The staff member faces termination.",
      "A28": "The advisory committee recommends approval.",
      "A29": "The regulatory consultant recommends approval.",
      "A30": "The company submits an application.",
      "A31": "The researcher submits an application.",
      "A32": "The trial meets endpoint criteria.",
      "A33": "The trial shows statistical significance.",
      "A34": "The biostatistician conducts an analysis.",
      "A35": "The data auditor detects an anomaly.",
      "A36": "The data auditor triggers an investigation.",
      "A37": "The drug passes quality control.",
      "A38": "The lab technician tests purity.",
      "A39": "The lab technician tests stability.",
      "A40": "The lab technician confirms specifications.",
      "A41": "The patient drops out.",
      "A42": "The whistleblower reports misconduct.",
      "A43": "The monitor reports misconduct.",
      "A44": "The regulator initiates an audit.",
      "A45": "The sponsor initiates an audit.",
      "A46": "The company seeks partnership.",
      "A47": "The researcher seeks collaboration.",
      "A48": "The data scientist analyzes data.",
      "A49": "The company launches the drug.",
      "A50": "The drug generates revenue.",
      "A51": "The manufacturer recalls the drug.",
      "A52": "The regulator recalls the drug.",
      "A53": "The patient shows no change.",
      "A54": "The patient shows deterioration.",
      "G": "The trial is successful."
    },
    "prover9_expressions": [
      "(administers(trial_coordinator, placebo) | successful(trial))",
      "(reports_adverse_event(patient) -> (passes_efficacy_check(drug) -> successful(trial)))",
      "(is_enrolled(patient, trial) -> (withdraws_from_trial(patient) | reports_adverse_event(patient)))",
      "(receives_medical_monitoring(patient) -> receives_compensation(patient))",
      "(achieves_primary_endpoint(trial) -> shows_improvement(patient))",
      "(achieves_primary_endpoint(trial) -> achieves_secondary_endpoint(trial))",
      "(achieves_secondary_endpoint(trial) -> shows_improvement(patient))",
      "(publishes_results(researcher) -> (achieves_secondary_endpoint(trial) -> shows_improvement(patient)))",
      "(publishes_results(researcher) | presents_at_conference(researcher))",
      "(presents_at_conference(researcher) -> (achieves_secondary_endpoint(trial) -> shows_improvement(patient)))",
      "(files_patent(company) | (publishes_results(researcher) | presents_at_conference(researcher)))",
      "(administers(trial_coordinator, experimental_drug) -> -administers(trial_coordinator, placebo))",
      "(licenses_technology(company) -> (files_patent(company) | (publishes_results(researcher) | presents_at_conference(researcher))))",
      "(licenses_technology(company) | acquires_company(pharma_giant))",
      "(acquires_company(pharma_giant) -> (files_patent(company) | (publishes_results(researcher) | presents_at_conference(researcher))))",
      "(acquires_company(pharma_giant) -> markets_drug(pharma_giant))",
      "(markets_drug(pharma_giant) -> (files_patent(company) | (publishes_results(researcher) | presents_at_conference(researcher))))",
      "(halts_trial(ethics_board) -> (-administers(trial_coordinator, experimental_drug) -> experiences_side_effect(patient)))",
      "(halts_trial(ethics_board) | halts_trial(data_safety_monitor))",
      "(halts_trial(data_safety_monitor) -> (-administers(trial_coordinator, experimental_drug) -> experiences_side_effect(patient)))",
      "(violates_protocol(staff_member) -> receives_warning(staff_member))",
      "(violates_protocol(staff_member) | (halts_trial(data_safety_monitor) -> (-administers(trial_coordinator, experimental_drug) -> experiences_side_effect(patient))))",
      "(recommends_approval(advisory_committee) -> (-administers(trial_coordinator, experimental_drug) -> experiences_side_effect(patient)))",
      "(recommends_approval(advisory_committee) | recommends_approval(regulatory_consultant))",
      "(recommends_approval(regulatory_consultant) -> (-administers(trial_coordinator, experimental_drug) -> experiences_side_effect(patient)))",
      "(submits_application(company) -> (recommends_approval(regulatory_consultant) -> (-administers(trial_coordinator, experimental_drug) -> experiences_side_effect(patient))))",
      "(submits_application(company) | submits_application(researcher))",
      "(submits_application(researcher) -> (recommends_approval(regulatory_consultant) -> (-administers(trial_coordinator, experimental_drug) -> experiences_side_effect(patient))))",
      "(shows_statistical_significance(trial) | -meets_endpoint_criteria(trial))",
      "(conducts_analysis(biostatistician) -> shows_statistical_significance(trial))",
      "(conducts_analysis(biostatistician) | detects_anomaly(data_auditor))",
      "(detects_anomaly(data_auditor) -> -meets_endpoint_criteria(trial))",
      "(passes_quality_control(drug) | -receives_approval(fda, trial))",
      "(tests_purity(lab_technician) -> passes_quality_control(drug))",
      "(tests_purity(lab_technician) | tests_stability(lab_technician))",
      "(tests_stability(lab_technician) -> confirms_specifications(lab_technician))",
      "(tests_stability(lab_technician) -> -receives_approval(fda, trial))",
      "(receives_approval(fda, trial) -> meets_endpoint_criteria(trial))",
      "(receives_approval(fda, trial) -> receives_funding(trial))",
      "(receives_approval(fda, trial) -> -receives_funding(trial))",
      "(receives_approval(fda, trial) | (-administers(trial_coordinator, experimental_drug) -> experiences_side_effect(patient)))",
      "(confirms_specifications(lab_technician) -> -receives_approval(fda, trial))",
      "(reports_misconduct(whistleblower) -> -drops_out(patient))",
      "(reports_misconduct(whistleblower) | reports_misconduct(monitor))",
      "(reports_misconduct(monitor) -> -drops_out(patient))",
      "(initiates_audit(regulator) -> (reports_misconduct(whistleblower) -> -drops_out(patient)))",
      "(initiates_audit(regulator) | initiates_audit(sponsor))",
      "(initiates_audit(sponsor) -> (reports_misconduct(whistleblower) -> -drops_out(patient)))",
      "(seeks_partnership(company) -> files_patent(company))",
      "(seeks_partnership(company) | seeks_collaboration(researcher))",
      "(seeks_collaboration(researcher) -> (publishes_results(researcher) | presents_at_conference(researcher)))",
      "(analyzes_data(data_scientist) -> (seeks_partnership(company) | seeks_collaboration(researcher)))",
      "(launches_drug(company) -> generates_revenue(drug))",
      "(launches_drug(company) | (acquires_company(pharma_giant) -> (files_patent(company) | (publishes_results(researcher) | presents_at_conference(researcher)))))",
      "(recalls_drug(manufacturer) -> -generates_revenue(drug))",
      "(recalls_drug(manufacturer) | recalls_drug(regulator))",
      "(recalls_drug(regulator) -> -generates_revenue(drug))",
      "(shows_deterioration(patient) -> -shows_no_change(patient))",
      "(passes_safety_check(drug) -> successful(trial))",
      "(passes_safety_check(drug) | passes_efficacy_check(drug))",
      "(passes_efficacy_check(drug) -> successful(trial))",
      "(completes_trial(patient) | (passes_efficacy_check(drug) -> successful(trial)))",
      "(withdraws_from_trial(patient) -> completes_trial(patient))",
      "(withdraws_from_trial(patient) | reports_adverse_event(patient))",
      "(-(violates_protocol(staff_member) -> receives_warning(staff_member)) -> faces_termination(staff_member))",
      "(-(detects_anomaly(data_auditor) -> -meets_endpoint_criteria(trial)) -> triggers_investigation(data_auditor))",
      "(-(withdraws_from_trial(patient) | reports_adverse_event(patient)) -> drops_out(patient))",
      "(-(-successful(trial) -> shows_improvement(patient)) -> shows_no_change(patient))",
      "(-(-successful(trial) -> shows_improvement(patient)) -> shows_deterioration(patient))",
      "(-(-successful(trial) -> shows_improvement(patient)) -> -shows_no_change(patient))",
      "(-is_enrolled(patient, trial) -> receives_compensation(patient))",
      "(-is_enrolled(patient, trial) -> receives_medical_monitoring(patient))",
      "(-administers(trial_coordinator, experimental_drug) -> experiences_side_effect(patient))",
      "(-administers(trial_coordinator, experimental_drug) -> -experiences_side_effect(patient))",
      "(-successful(trial) -> shows_improvement(patient))",
      "(-successful(trial) -> achieves_primary_endpoint(trial))",
      "is_enrolled(patient, trial)",
      "administers(trial_coordinator, experimental_drug)",
      "analyzes_data(data_scientist)",
      "successful(trial)",
      "-administers(trial_coordinator, placebo)",
      "-receives_compensation(patient)",
      "-shows_improvement(patient)",
      "-files_patent(company)",
      "-violates_protocol(staff_member)",
      "-receives_warning(staff_member)",
      "-faces_termination(staff_member)",
      "-meets_endpoint_criteria(trial)",
      "-shows_statistical_significance(trial)",
      "-triggers_investigation(data_auditor)",
      "-passes_quality_control(drug)",
      "-receives_approval(fda, trial)",
      "-drops_out(patient)",
      "-launches_drug(company)",
      "-generates_revenue(drug)",
      "-completes_trial(patient)"
    ],
    "natural_expressions": [
      "Either the trial coordinator administers the placebo or the trial is successful.",
      "If the patient reports an adverse event, then, provided that the drug passes the efficacy check, the trial is successful.",
      "If the patient is enrolled in the trial, then either the patient withdraws from the trial or the patient reports an adverse event.",
      "Under the condition that the patient receives medical monitoring, the patient receives compensation.",
      "Whenever the trial achieves its primary endpoint, the patient shows improvement.",
      "In the event that the trial achieves its primary endpoint, the trial achieves its secondary endpoint.",
      "Given that the trial achieves its secondary endpoint, the patient shows improvement.",
      "If the researcher publishes the results, then, provided that the trial achieves its secondary endpoint, the patient shows improvement.",
      "The researcher publishes the results or the researcher presents at a conference.",
      "Whenever the researcher presents at a conference, then, under the condition that the trial achieves its secondary endpoint, the patient shows improvement.",
      "The company files a patent, or the researcher publishes the results, or the researcher presents at a conference.",
      "Provided that the trial coordinator administers the experimental drug, it is not the case that the trial coordinator administers the placebo.",
      "If the company licenses the technology, then the company files a patent or the researcher publishes the results or the researcher presents at a conference.",
      "Either the company licenses the technology or the pharma giant acquires the company.",
      "In the event that the pharma giant acquires the company, the company files a patent or the researcher publishes the results or the researcher presents at a conference.",
      "Provided that the pharma giant acquires the company, the pharma giant markets the drug.",
      "Whenever the pharma giant markets the drug, the company files a patent or the researcher publishes the results or the researcher presents at a conference.",
      "If the ethics board halts the trial, then, given that the trial coordinator does not administer the experimental drug, the patient experiences a side effect.",
      "Either the ethics board halts the trial or the data safety monitor halts the trial.",
      "Under the condition that the data safety monitor halts the trial, then, provided that the trial coordinator does not administer the experimental drug, the patient experiences a side effect.",
      "If the staff member violates the protocol, then the staff member receives a warning.",
      "The staff member violates the protocol or, if the data safety monitor halts the trial, then, given that the trial coordinator does not administer the experimental drug, the patient experiences a side effect.",
      "Provided that the advisory committee recommends approval, then, whenever the trial coordinator does not administer the experimental drug, the patient experiences a side effect.",
      "Either the advisory committee recommends approval or the regulatory consultant recommends approval.",
      "In the event that the regulatory consultant recommends approval, then, under the condition that the trial coordinator does not administer the experimental drug, the patient experiences a side effect.",
      "If the company submits an application, then, provided that the regulatory consultant recommends approval, whenever the trial coordinator does not administer the experimental drug, the patient experiences a side effect.",
      "The company submits an application or the researcher submits an application.",
      "Whenever the researcher submits an application, then, given that the regulatory consultant recommends approval, under the condition that the trial coordinator does not administer the experimental drug, the patient experiences a side effect.",
      "Either the trial shows statistical significance or the trial does not meet endpoint criteria.",
      "Provided that the biostatistician conducts an analysis, the trial shows statistical significance.",
      "The biostatistician conducts an analysis or the data auditor detects an anomaly.",
      "If the data auditor detects an anomaly, then the trial does not meet endpoint criteria.",
      "Either the drug passes quality control or the FDA does not receive approval for the trial.",
      "Under the condition that the lab technician tests purity, the drug passes quality control.",
      "The lab technician tests purity or the lab technician tests stability.",
      "Whenever the lab technician tests stability, the lab technician confirms specifications.",
      "Provided that the lab technician tests stability, the FDA does not receive approval for the trial.",
      "If the FDA receives approval for the trial, then the trial meets endpoint criteria.",
      "Given that the FDA receives approval for the trial, the trial receives funding.",
      "In the event that the FDA receives approval for the trial, the trial does not receive funding.",
      "The FDA receives approval for the trial or, provided that the trial coordinator does not administer the experimental drug, the patient experiences a side effect.",
      "If the lab technician confirms specifications, then the FDA does not receive approval for the trial.",
      "Provided that the whistleblower reports misconduct, the patient does not drop out.",
      "Either the whistleblower reports misconduct or the monitor reports misconduct.",
      "Under the condition that the monitor reports misconduct, the patient does not drop out.",
      "If the regulator initiates an audit, then, given that the whistleblower reports misconduct, the patient does not drop out.",
      "The regulator initiates an audit or the sponsor initiates an audit.",
      "Whenever the sponsor initiates an audit, then, provided that the whistleblower reports misconduct, the patient does not drop out.",
      "In the event that the company seeks partnership, the company files a patent.",
      "Either the company seeks partnership or the researcher seeks collaboration.",
      "Provided that the researcher seeks collaboration, the researcher publishes the results or the researcher presents at a conference.",
      "If the data scientist analyzes data, then the company seeks partnership or the researcher seeks collaboration.",
      "Under the condition that the company launches the drug, the drug generates revenue.",
      "The company launches the drug or, if the pharma giant acquires the company, then the company files a patent or the researcher publishes the results or the researcher presents at a conference.",
      "Provided that the manufacturer recalls the drug, the drug does not generate revenue.",
      "Either the manufacturer recalls the drug or the regulator recalls the drug.",
      "Whenever the regulator recalls the drug, the drug does not generate revenue.",
      "If the patient shows deterioration, then the patient does not show no change.",
      "Given that the drug passes the safety check, the trial is successful.",
      "Either the drug passes the safety check or the drug passes the efficacy check.",
      "Under the condition that the drug passes the efficacy check, the trial is successful.",
      "The patient completes the trial or, provided that the drug passes the efficacy check, the trial is successful.",
      "If the patient withdraws from the trial, then the patient completes the trial.",
      "Either the patient withdraws from the trial or the patient reports an adverse event.",
      "If it is not the case that, if the staff member violates the protocol then the staff member receives a warning, then the staff member faces termination.",
      "Provided that it is not the case that, if the data auditor detects an anomaly then the trial does not meet endpoint criteria, the data auditor triggers an investigation.",
      "If it is not the case that the patient withdraws from the trial or the patient reports an adverse event, then the patient drops out.",
      "Given that it is not the case that, if the trial is not successful then the patient shows improvement, the patient shows no change.",
      "Under the condition that it is not the case that, if the trial is not successful then the patient shows improvement, the patient shows deterioration.",
      "Whenever it is not the case that, if the trial is not successful then the patient shows improvement, the patient does not show no change.",
      "If the patient is not enrolled in the trial, then the patient receives compensation.",
      "Provided that the patient is not enrolled in the trial, the patient receives medical monitoring.",
      "In the event that the trial coordinator does not administer the experimental drug, the patient experiences a side effect.",
      "If the trial coordinator does not administer the experimental drug, then the patient does not experience a side effect.",
      "Given that the trial is not successful, the patient shows improvement.",
      "Under the condition that the trial is not successful, the trial achieves its primary endpoint.",
      "The patient is enrolled in the trial.",
      "The trial coordinator administers the experimental drug.",
      "The data scientist analyzes data.",
      "The trial is successful.",
      "It is not the case that the trial coordinator administers the placebo.",
      "The patient does not receive compensation.",
      "The patient does not show improvement.",
      "The company does not file a patent.",
      "The staff member does not violate the protocol.",
      "The staff member does not receive a warning.",
      "The staff member does not face termination.",
      "The trial does not meet endpoint criteria.",
      "The trial does not show statistical significance.",
      "The data auditor does not trigger an investigation.",
      "The drug does not pass quality control.",
      "The FDA does not receive approval for the trial.",
      "The patient does not drop out.",
      "The company does not launch the drug.",
      "The drug does not generate revenue.",
      "The patient does not complete the trial."
    ],
    "node_mappings": {
      "(A1 ∨ G)": {
        "formal": "(A1 ∨ G)",
        "prover9": "(A1 | G)",
        "prover9_expression": "(administers(trial_coordinator, placebo) | successful(trial))",
        "natural": "Either the trial coordinator administers the placebo or the trial is successful."
      },
      "(A10 → (A7 → G))": {
        "formal": "(A10 → (A7 → G))",
        "prover9": "(A10 -> (A7 -> G))",
        "prover9_expression": "(reports_adverse_event(patient) -> (passes_efficacy_check(drug) -> successful(trial)))",
        "natural": "If the patient reports an adverse event, then, provided that the drug passes the efficacy check, the trial is successful."
      },
      "(A11 → (A9 ∨ A10))": {
        "formal": "(A11 → (A9 ∨ A10))",
        "prover9": "(A11 -> (A9 | A10))",
        "prover9_expression": "(is_enrolled(patient, trial) -> (withdraws_from_trial(patient) | reports_adverse_event(patient)))",
        "natural": "If the patient is enrolled in the trial, then either the patient withdraws from the trial or the patient reports an adverse event."
      },
      "(A13 → A12)": {
        "formal": "(A13 → A12)",
        "prover9": "(A13 -> A12)",
        "prover9_expression": "(receives_medical_monitoring(patient) -> receives_compensation(patient))",
        "natural": "Under the condition that the patient receives medical monitoring, the patient receives compensation."
      },
      "(A15 → A14)": {
        "formal": "(A15 → A14)",
        "prover9": "(A15 -> A14)",
        "prover9_expression": "(achieves_primary_endpoint(trial) -> shows_improvement(patient))",
        "natural": "Whenever the trial achieves its primary endpoint, the patient shows improvement."
      },
      "(A15 → A16)": {
        "formal": "(A15 → A16)",
        "prover9": "(A15 -> A16)",
        "prover9_expression": "(achieves_primary_endpoint(trial) -> achieves_secondary_endpoint(trial))",
        "natural": "In the event that the trial achieves its primary endpoint, the trial achieves its secondary endpoint."
      },
      "(A16 → A14)": {
        "formal": "(A16 → A14)",
        "prover9": "(A16 -> A14)",
        "prover9_expression": "(achieves_secondary_endpoint(trial) -> shows_improvement(patient))",
        "natural": "Given that the trial achieves its secondary endpoint, the patient shows improvement."
      },
      "(A17 → (A16 → A14))": {
        "formal": "(A17 → (A16 → A14))",
        "prover9": "(A17 -> (A16 -> A14))",
        "prover9_expression": "(publishes_results(researcher) -> (achieves_secondary_endpoint(trial) -> shows_improvement(patient)))",
        "natural": "If the researcher publishes the results, then, provided that the trial achieves its secondary endpoint, the patient shows improvement."
      },
      "(A17 ∨ A18)": {
        "formal": "(A17 ∨ A18)",
        "prover9": "(A17 | A18)",
        "prover9_expression": "(publishes_results(researcher) | presents_at_conference(researcher))",
        "natural": "The researcher publishes the results or the researcher presents at a conference."
      },
      "(A18 → (A16 → A14))": {
        "formal": "(A18 → (A16 → A14))",
        "prover9": "(A18 -> (A16 -> A14))",
        "prover9_expression": "(presents_at_conference(researcher) -> (achieves_secondary_endpoint(trial) -> shows_improvement(patient)))",
        "natural": "Whenever the researcher presents at a conference, then, under the condition that the trial achieves its secondary endpoint, the patient shows improvement."
      },
      "(A19 ∨ (A17 ∨ A18))": {
        "formal": "(A19 ∨ (A17 ∨ A18))",
        "prover9": "(A19 | (A17 | A18))",
        "prover9_expression": "(files_patent(company) | (publishes_results(researcher) | presents_at_conference(researcher)))",
        "natural": "The company files a patent, or the researcher publishes the results, or the researcher presents at a conference."
      },
      "(A2 → ¬A1)": {
        "formal": "(A2 → ¬A1)",
        "prover9": "(A2 -> -A1)",
        "prover9_expression": "(administers(trial_coordinator, experimental_drug) -> -administers(trial_coordinator, placebo))",
        "natural": "Provided that the trial coordinator administers the experimental drug, it is not the case that the trial coordinator administers the placebo."
      },
      "(A20 → (A19 ∨ (A17 ∨ A18)))": {
        "formal": "(A20 → (A19 ∨ (A17 ∨ A18)))",
        "prover9": "(A20 -> (A19 | (A17 | A18)))",
        "prover9_expression": "(licenses_technology(company) -> (files_patent(company) | (publishes_results(researcher) | presents_at_conference(researcher))))",
        "natural": "If the company licenses the technology, then the company files a patent or the researcher publishes the results or the researcher presents at a conference."
      },
      "(A20 ∨ A21)": {
        "formal": "(A20 ∨ A21)",
        "prover9": "(A20 | A21)",
        "prover9_expression": "(licenses_technology(company) | acquires_company(pharma_giant))",
        "natural": "Either the company licenses the technology or the pharma giant acquires the company."
      },
      "(A21 → (A19 ∨ (A17 ∨ A18)))": {
        "formal": "(A21 → (A19 ∨ (A17 ∨ A18)))",
        "prover9": "(A21 -> (A19 | (A17 | A18)))",
        "prover9_expression": "(acquires_company(pharma_giant) -> (files_patent(company) | (publishes_results(researcher) | presents_at_conference(researcher))))",
        "natural": "In the event that the pharma giant acquires the company, the company files a patent or the researcher publishes the results or the researcher presents at a conference."
      },
      "(A21 → A22)": {
        "formal": "(A21 → A22)",
        "prover9": "(A21 -> A22)",
        "prover9_expression": "(acquires_company(pharma_giant) -> markets_drug(pharma_giant))",
        "natural": "Provided that the pharma giant acquires the company, the pharma giant markets the drug."
      },
      "(A22 → (A19 ∨ (A17 ∨ A18)))": {
        "formal": "(A22 → (A19 ∨ (A17 ∨ A18)))",
        "prover9": "(A22 -> (A19 | (A17 | A18)))",
        "prover9_expression": "(markets_drug(pharma_giant) -> (files_patent(company) | (publishes_results(researcher) | presents_at_conference(researcher))))",
        "natural": "Whenever the pharma giant markets the drug, the company files a patent or the researcher publishes the results or the researcher presents at a conference."
      },
      "(A23 → (¬A2 → A3))": {
        "formal": "(A23 → (¬A2 → A3))",
        "prover9": "(A23 -> (-A2 -> A3))",
        "prover9_expression": "(halts_trial(ethics_board) -> (-administers(trial_coordinator, experimental_drug) -> experiences_side_effect(patient)))",
        "natural": "If the ethics board halts the trial, then, given that the trial coordinator does not administer the experimental drug, the patient experiences a side effect."
      },
      "(A23 ∨ A24)": {
        "formal": "(A23 ∨ A24)",
        "prover9": "(A23 | A24)",
        "prover9_expression": "(halts_trial(ethics_board) | halts_trial(data_safety_monitor))",
        "natural": "Either the ethics board halts the trial or the data safety monitor halts the trial."
      },
      "(A24 → (¬A2 → A3))": {
        "formal": "(A24 → (¬A2 → A3))",
        "prover9": "(A24 -> (-A2 -> A3))",
        "prover9_expression": "(halts_trial(data_safety_monitor) -> (-administers(trial_coordinator, experimental_drug) -> experiences_side_effect(patient)))",
        "natural": "Under the condition that the data safety monitor halts the trial, then, provided that the trial coordinator does not administer the experimental drug, the patient experiences a side effect."
      },
      "(A25 → A26)": {
        "formal": "(A25 → A26)",
        "prover9": "(A25 -> A26)",
        "prover9_expression": "(violates_protocol(staff_member) -> receives_warning(staff_member))",
        "natural": "If the staff member violates the protocol, then the staff member receives a warning."
      },
      "(A25 ∨ (A24 → (¬A2 → A3)))": {
        "formal": "(A25 ∨ (A24 → (¬A2 → A3)))",
        "prover9": "(A25 | (A24 -> (-A2 -> A3)))",
        "prover9_expression": "(violates_protocol(staff_member) | (halts_trial(data_safety_monitor) -> (-administers(trial_coordinator, experimental_drug) -> experiences_side_effect(patient))))",
        "natural": "The staff member violates the protocol or, if the data safety monitor halts the trial, then, given that the trial coordinator does not administer the experimental drug, the patient experiences a side effect."
      },
      "(A28 → (¬A2 → A3))": {
        "formal": "(A28 → (¬A2 → A3))",
        "prover9": "(A28 -> (-A2 -> A3))",
        "prover9_expression": "(recommends_approval(advisory_committee) -> (-administers(trial_coordinator, experimental_drug) -> experiences_side_effect(patient)))",
        "natural": "Provided that the advisory committee recommends approval, then, whenever the trial coordinator does not administer the experimental drug, the patient experiences a side effect."
      },
      "(A28 ∨ A29)": {
        "formal": "(A28 ∨ A29)",
        "prover9": "(A28 | A29)",
        "prover9_expression": "(recommends_approval(advisory_committee) | recommends_approval(regulatory_consultant))",
        "natural": "Either the advisory committee recommends approval or the regulatory consultant recommends approval."
      },
      "(A29 → (¬A2 → A3))": {
        "formal": "(A29 → (¬A2 → A3))",
        "prover9": "(A29 -> (-A2 -> A3))",
        "prover9_expression": "(recommends_approval(regulatory_consultant) -> (-administers(trial_coordinator, experimental_drug) -> experiences_side_effect(patient)))",
        "natural": "In the event that the regulatory consultant recommends approval, then, under the condition that the trial coordinator does not administer the experimental drug, the patient experiences a side effect."
      },
      "(A30 → (A29 → (¬A2 → A3)))": {
        "formal": "(A30 → (A29 → (¬A2 → A3)))",
        "prover9": "(A30 -> (A29 -> (-A2 -> A3)))",
        "prover9_expression": "(submits_application(company) -> (recommends_approval(regulatory_consultant) -> (-administers(trial_coordinator, experimental_drug) -> experiences_side_effect(patient))))",
        "natural": "If the company submits an application, then, provided that the regulatory consultant recommends approval, whenever the trial coordinator does not administer the experimental drug, the patient experiences a side effect."
      },
      "(A30 ∨ A31)": {
        "formal": "(A30 ∨ A31)",
        "prover9": "(A30 | A31)",
        "prover9_expression": "(submits_application(company) | submits_application(researcher))",
        "natural": "The company submits an application or the researcher submits an application."
      },
      "(A31 → (A29 → (¬A2 → A3)))": {
        "formal": "(A31 → (A29 → (¬A2 → A3)))",
        "prover9": "(A31 -> (A29 -> (-A2 -> A3)))",
        "prover9_expression": "(submits_application(researcher) -> (recommends_approval(regulatory_consultant) -> (-administers(trial_coordinator, experimental_drug) -> experiences_side_effect(patient))))",
        "natural": "Whenever the researcher submits an application, then, given that the regulatory consultant recommends approval, under the condition that the trial coordinator does not administer the experimental drug, the patient experiences a side effect."
      },
      "(A33 ∨ ¬A32)": {
        "formal": "(A33 ∨ ¬A32)",
        "prover9": "(A33 | -A32)",
        "prover9_expression": "(shows_statistical_significance(trial) | -meets_endpoint_criteria(trial))",
        "natural": "Either the trial shows statistical significance or the trial does not meet endpoint criteria."
      },
      "(A34 → A33)": {
        "formal": "(A34 → A33)",
        "prover9": "(A34 -> A33)",
        "prover9_expression": "(conducts_analysis(biostatistician) -> shows_statistical_significance(trial))",
        "natural": "Provided that the biostatistician conducts an analysis, the trial shows statistical significance."
      },
      "(A34 ∨ A35)": {
        "formal": "(A34 ∨ A35)",
        "prover9": "(A34 | A35)",
        "prover9_expression": "(conducts_analysis(biostatistician) | detects_anomaly(data_auditor))",
        "natural": "The biostatistician conducts an analysis or the data auditor detects an anomaly."
      },
      "(A35 → ¬A32)": {
        "formal": "(A35 → ¬A32)",
        "prover9": "(A35 -> -A32)",
        "prover9_expression": "(detects_anomaly(data_auditor) -> -meets_endpoint_criteria(trial))",
        "natural": "If the data auditor detects an anomaly, then the trial does not meet endpoint criteria."
      },
      "(A37 ∨ ¬A4)": {
        "formal": "(A37 ∨ ¬A4)",
        "prover9": "(A37 | -A4)",
        "prover9_expression": "(passes_quality_control(drug) | -receives_approval(fda, trial))",
        "natural": "Either the drug passes quality control or the FDA does not receive approval for the trial."
      },
      "(A38 → A37)": {
        "formal": "(A38 → A37)",
        "prover9": "(A38 -> A37)",
        "prover9_expression": "(tests_purity(lab_technician) -> passes_quality_control(drug))",
        "natural": "Under the condition that the lab technician tests purity, the drug passes quality control."
      },
      "(A38 ∨ A39)": {
        "formal": "(A38 ∨ A39)",
        "prover9": "(A38 | A39)",
        "prover9_expression": "(tests_purity(lab_technician) | tests_stability(lab_technician))",
        "natural": "The lab technician tests purity or the lab technician tests stability."
      },
      "(A39 → A40)": {
        "formal": "(A39 → A40)",
        "prover9": "(A39 -> A40)",
        "prover9_expression": "(tests_stability(lab_technician) -> confirms_specifications(lab_technician))",
        "natural": "Whenever the lab technician tests stability, the lab technician confirms specifications."
      },
      "(A39 → ¬A4)": {
        "formal": "(A39 → ¬A4)",
        "prover9": "(A39 -> -A4)",
        "prover9_expression": "(tests_stability(lab_technician) -> -receives_approval(fda, trial))",
        "natural": "Provided that the lab technician tests stability, the FDA does not receive approval for the trial."
      },
      "(A4 → A32)": {
        "formal": "(A4 → A32)",
        "prover9": "(A4 -> A32)",
        "prover9_expression": "(receives_approval(fda, trial) -> meets_endpoint_criteria(trial))",
        "natural": "If the FDA receives approval for the trial, then the trial meets endpoint criteria."
      },
      "(A4 → A5)": {
        "formal": "(A4 → A5)",
        "prover9": "(A4 -> A5)",
        "prover9_expression": "(receives_approval(fda, trial) -> receives_funding(trial))",
        "natural": "Given that the FDA receives approval for the trial, the trial receives funding."
      },
      "(A4 → ¬A5)": {
        "formal": "(A4 → ¬A5)",
        "prover9": "(A4 -> -A5)",
        "prover9_expression": "(receives_approval(fda, trial) -> -receives_funding(trial))",
        "natural": "In the event that the FDA receives approval for the trial, the trial does not receive funding."
      },
      "(A4 ∨ (¬A2 → A3))": {
        "formal": "(A4 ∨ (¬A2 → A3))",
        "prover9": "(A4 | (-A2 -> A3))",
        "prover9_expression": "(receives_approval(fda, trial) | (-administers(trial_coordinator, experimental_drug) -> experiences_side_effect(patient)))",
        "natural": "The FDA receives approval for the trial or, provided that the trial coordinator does not administer the experimental drug, the patient experiences a side effect."
      },
      "(A40 → ¬A4)": {
        "formal": "(A40 → ¬A4)",
        "prover9": "(A40 -> -A4)",
        "prover9_expression": "(confirms_specifications(lab_technician) -> -receives_approval(fda, trial))",
        "natural": "If the lab technician confirms specifications, then the FDA does not receive approval for the trial."
      },
      "(A42 → ¬A41)": {
        "formal": "(A42 → ¬A41)",
        "prover9": "(A42 -> -A41)",
        "prover9_expression": "(reports_misconduct(whistleblower) -> -drops_out(patient))",
        "natural": "Provided that the whistleblower reports misconduct, the patient does not drop out."
      },
      "(A42 ∨ A43)": {
        "formal": "(A42 ∨ A43)",
        "prover9": "(A42 | A43)",
        "prover9_expression": "(reports_misconduct(whistleblower) | reports_misconduct(monitor))",
        "natural": "Either the whistleblower reports misconduct or the monitor reports misconduct."
      },
      "(A43 → ¬A41)": {
        "formal": "(A43 → ¬A41)",
        "prover9": "(A43 -> -A41)",
        "prover9_expression": "(reports_misconduct(monitor) -> -drops_out(patient))",
        "natural": "Under the condition that the monitor reports misconduct, the patient does not drop out."
      },
      "(A44 → (A42 → ¬A41))": {
        "formal": "(A44 → (A42 → ¬A41))",
        "prover9": "(A44 -> (A42 -> -A41))",
        "prover9_expression": "(initiates_audit(regulator) -> (reports_misconduct(whistleblower) -> -drops_out(patient)))",
        "natural": "If the regulator initiates an audit, then, given that the whistleblower reports misconduct, the patient does not drop out."
      },
      "(A44 ∨ A45)": {
        "formal": "(A44 ∨ A45)",
        "prover9": "(A44 | A45)",
        "prover9_expression": "(initiates_audit(regulator) | initiates_audit(sponsor))",
        "natural": "The regulator initiates an audit or the sponsor initiates an audit."
      },
      "(A45 → (A42 → ¬A41))": {
        "formal": "(A45 → (A42 → ¬A41))",
        "prover9": "(A45 -> (A42 -> -A41))",
        "prover9_expression": "(initiates_audit(sponsor) -> (reports_misconduct(whistleblower) -> -drops_out(patient)))",
        "natural": "Whenever the sponsor initiates an audit, then, provided that the whistleblower reports misconduct, the patient does not drop out."
      },
      "(A46 → A19)": {
        "formal": "(A46 → A19)",
        "prover9": "(A46 -> A19)",
        "prover9_expression": "(seeks_partnership(company) -> files_patent(company))",
        "natural": "In the event that the company seeks partnership, the company files a patent."
      },
      "(A46 ∨ A47)": {
        "formal": "(A46 ∨ A47)",
        "prover9": "(A46 | A47)",
        "prover9_expression": "(seeks_partnership(company) | seeks_collaboration(researcher))",
        "natural": "Either the company seeks partnership or the researcher seeks collaboration."
      },
      "(A47 → (A17 ∨ A18))": {
        "formal": "(A47 → (A17 ∨ A18))",
        "prover9": "(A47 -> (A17 | A18))",
        "prover9_expression": "(seeks_collaboration(researcher) -> (publishes_results(researcher) | presents_at_conference(researcher)))",
        "natural": "Provided that the researcher seeks collaboration, the researcher publishes the results or the researcher presents at a conference."
      },
      "(A48 → (A46 ∨ A47))": {
        "formal": "(A48 → (A46 ∨ A47))",
        "prover9": "(A48 -> (A46 | A47))",
        "prover9_expression": "(analyzes_data(data_scientist) -> (seeks_partnership(company) | seeks_collaboration(researcher)))",
        "natural": "If the data scientist analyzes data, then the company seeks partnership or the researcher seeks collaboration."
      },
      "(A49 → A50)": {
        "formal": "(A49 → A50)",
        "prover9": "(A49 -> A50)",
        "prover9_expression": "(launches_drug(company) -> generates_revenue(drug))",
        "natural": "Under the condition that the company launches the drug, the drug generates revenue."
      },
      "(A49 ∨ (A21 → (A19 ∨ (A17 ∨ A18))))": {
        "formal": "(A49 ∨ (A21 → (A19 ∨ (A17 ∨ A18))))",
        "prover9": "(A49 | (A21 -> (A19 | (A17 | A18))))",
        "prover9_expression": "(launches_drug(company) | (acquires_company(pharma_giant) -> (files_patent(company) | (publishes_results(researcher) | presents_at_conference(researcher)))))",
        "natural": "The company launches the drug or, if the pharma giant acquires the company, then the company files a patent or the researcher publishes the results or the researcher presents at a conference."
      },
      "(A51 → ¬A50)": {
        "formal": "(A51 → ¬A50)",
        "prover9": "(A51 -> -A50)",
        "prover9_expression": "(recalls_drug(manufacturer) -> -generates_revenue(drug))",
        "natural": "Provided that the manufacturer recalls the drug, the drug does not generate revenue."
      },
      "(A51 ∨ A52)": {
        "formal": "(A51 ∨ A52)",
        "prover9": "(A51 | A52)",
        "prover9_expression": "(recalls_drug(manufacturer) | recalls_drug(regulator))",
        "natural": "Either the manufacturer recalls the drug or the regulator recalls the drug."
      },
      "(A52 → ¬A50)": {
        "formal": "(A52 → ¬A50)",
        "prover9": "(A52 -> -A50)",
        "prover9_expression": "(recalls_drug(regulator) -> -generates_revenue(drug))",
        "natural": "Whenever the regulator recalls the drug, the drug does not generate revenue."
      },
      "(A54 → ¬A53)": {
        "formal": "(A54 → ¬A53)",
        "prover9": "(A54 -> -A53)",
        "prover9_expression": "(shows_deterioration(patient) -> -shows_no_change(patient))",
        "natural": "If the patient shows deterioration, then the patient does not show no change."
      },
      "(A6 → G)": {
        "formal": "(A6 → G)",
        "prover9": "(A6 -> G)",
        "prover9_expression": "(passes_safety_check(drug) -> successful(trial))",
        "natural": "Given that the drug passes the safety check, the trial is successful."
      },
      "(A6 ∨ A7)": {
        "formal": "(A6 ∨ A7)",
        "prover9": "(A6 | A7)",
        "prover9_expression": "(passes_safety_check(drug) | passes_efficacy_check(drug))",
        "natural": "Either the drug passes the safety check or the drug passes the efficacy check."
      },
      "(A7 → G)": {
        "formal": "(A7 → G)",
        "prover9": "(A7 -> G)",
        "prover9_expression": "(passes_efficacy_check(drug) -> successful(trial))",
        "natural": "Under the condition that the drug passes the efficacy check, the trial is successful."
      },
      "(A8 ∨ (A7 → G))": {
        "formal": "(A8 ∨ (A7 → G))",
        "prover9": "(A8 | (A7 -> G))",
        "prover9_expression": "(completes_trial(patient) | (passes_efficacy_check(drug) -> successful(trial)))",
        "natural": "The patient completes the trial or, provided that the drug passes the efficacy check, the trial is successful."
      },
      "(A9 → A8)": {
        "formal": "(A9 → A8)",
        "prover9": "(A9 -> A8)",
        "prover9_expression": "(withdraws_from_trial(patient) -> completes_trial(patient))",
        "natural": "If the patient withdraws from the trial, then the patient completes the trial."
      },
      "(A9 ∨ A10)": {
        "formal": "(A9 ∨ A10)",
        "prover9": "(A9 | A10)",
        "prover9_expression": "(withdraws_from_trial(patient) | reports_adverse_event(patient))",
        "natural": "Either the patient withdraws from the trial or the patient reports an adverse event."
      },
      "(¬(A25 → A26) → A27)": {
        "formal": "(¬(A25 → A26) → A27)",
        "prover9": "(-(A25 -> A26) -> A27)",
        "prover9_expression": "(-(violates_protocol(staff_member) -> receives_warning(staff_member)) -> faces_termination(staff_member))",
        "natural": "If it is not the case that, if the staff member violates the protocol then the staff member receives a warning, then the staff member faces termination."
      },
      "(¬(A35 → ¬A32) → A36)": {
        "formal": "(¬(A35 → ¬A32) → A36)",
        "prover9": "(-(A35 -> -A32) -> A36)",
        "prover9_expression": "(-(detects_anomaly(data_auditor) -> -meets_endpoint_criteria(trial)) -> triggers_investigation(data_auditor))",
        "natural": "Provided that it is not the case that, if the data auditor detects an anomaly then the trial does not meet endpoint criteria, the data auditor triggers an investigation."
      },
      "(¬(A9 ∨ A10) → A41)": {
        "formal": "(¬(A9 ∨ A10) → A41)",
        "prover9": "(-(A9 | A10) -> A41)",
        "prover9_expression": "(-(withdraws_from_trial(patient) | reports_adverse_event(patient)) -> drops_out(patient))",
        "natural": "If it is not the case that the patient withdraws from the trial or the patient reports an adverse event, then the patient drops out."
      },
      "(¬(¬G → A14) → A53)": {
        "formal": "(¬(¬G → A14) → A53)",
        "prover9": "(-(-G -> A14) -> A53)",
        "prover9_expression": "(-(-successful(trial) -> shows_improvement(patient)) -> shows_no_change(patient))",
        "natural": "Given that it is not the case that, if the trial is not successful then the patient shows improvement, the patient shows no change."
      },
      "(¬(¬G → A14) → A54)": {
        "formal": "(¬(¬G → A14) → A54)",
        "prover9": "(-(-G -> A14) -> A54)",
        "prover9_expression": "(-(-successful(trial) -> shows_improvement(patient)) -> shows_deterioration(patient))",
        "natural": "Under the condition that it is not the case that, if the trial is not successful then the patient shows improvement, the patient shows deterioration."
      },
      "(¬(¬G → A14) → ¬A53)": {
        "formal": "(¬(¬G → A14) → ¬A53)",
        "prover9": "(-(-G -> A14) -> -A53)",
        "prover9_expression": "(-(-successful(trial) -> shows_improvement(patient)) -> -shows_no_change(patient))",
        "natural": "Whenever it is not the case that, if the trial is not successful then the patient shows improvement, the patient does not show no change."
      },
      "(¬A11 → A12)": {
        "formal": "(¬A11 → A12)",
        "prover9": "(-A11 -> A12)",
        "prover9_expression": "(-is_enrolled(patient, trial) -> receives_compensation(patient))",
        "natural": "If the patient is not enrolled in the trial, then the patient receives compensation."
      },
      "(¬A11 → A13)": {
        "formal": "(¬A11 → A13)",
        "prover9": "(-A11 -> A13)",
        "prover9_expression": "(-is_enrolled(patient, trial) -> receives_medical_monitoring(patient))",
        "natural": "Provided that the patient is not enrolled in the trial, the patient receives medical monitoring."
      },
      "(¬A2 → A3)": {
        "formal": "(¬A2 → A3)",
        "prover9": "(-A2 -> A3)",
        "prover9_expression": "(-administers(trial_coordinator, experimental_drug) -> experiences_side_effect(patient))",
        "natural": "In the event that the trial coordinator does not administer the experimental drug, the patient experiences a side effect."
      },
      "(¬A2 → ¬A3)": {
        "formal": "(¬A2 → ¬A3)",
        "prover9": "(-A2 -> -A3)",
        "prover9_expression": "(-administers(trial_coordinator, experimental_drug) -> -experiences_side_effect(patient))",
        "natural": "If the trial coordinator does not administer the experimental drug, then the patient does not experience a side effect."
      },
      "(¬G → A14)": {
        "formal": "(¬G → A14)",
        "prover9": "(-G -> A14)",
        "prover9_expression": "(-successful(trial) -> shows_improvement(patient))",
        "natural": "Given that the trial is not successful, the patient shows improvement."
      },
      "(¬G → A15)": {
        "formal": "(¬G → A15)",
        "prover9": "(-G -> A15)",
        "prover9_expression": "(-successful(trial) -> achieves_primary_endpoint(trial))",
        "natural": "Under the condition that the trial is not successful, the trial achieves its primary endpoint."
      },
      "A11": {
        "formal": "A11",
        "prover9": "A11",
        "prover9_expression": "is_enrolled(patient, trial)",
        "natural": "The patient is enrolled in the trial."
      },
      "A2": {
        "formal": "A2",
        "prover9": "A2",
        "prover9_expression": "administers(trial_coordinator, experimental_drug)",
        "natural": "The trial coordinator administers the experimental drug."
      },
      "A48": {
        "formal": "A48",
        "prover9": "A48",
        "prover9_expression": "analyzes_data(data_scientist)",
        "natural": "The data scientist analyzes data."
      },
      "G": {
        "formal": "G",
        "prover9": "G",
        "prover9_expression": "successful(trial)",
        "natural": "The trial is successful."
      },
      "¬A1": {
        "formal": "¬A1",
        "prover9": "-A1",
        "prover9_expression": "-administers(trial_coordinator, placebo)",
        "natural": "It is not the case that the trial coordinator administers the placebo."
      },
      "¬A12": {
        "formal": "¬A12",
        "prover9": "-A12",
        "prover9_expression": "-receives_compensation(patient)",
        "natural": "The patient does not receive compensation."
      },
      "¬A14": {
        "formal": "¬A14",
        "prover9": "-A14",
        "prover9_expression": "-shows_improvement(patient)",
        "natural": "The patient does not show improvement."
      },
      "¬A19": {
        "formal": "¬A19",
        "prover9": "-A19",
        "prover9_expression": "-files_patent(company)",
        "natural": "The company does not file a patent."
      },
      "¬A25": {
        "formal": "¬A25",
        "prover9": "-A25",
        "prover9_expression": "-violates_protocol(staff_member)",
        "natural": "The staff member does not violate the protocol."
      },
      "¬A26": {
        "formal": "¬A26",
        "prover9": "-A26",
        "prover9_expression": "-receives_warning(staff_member)",
        "natural": "The staff member does not receive a warning."
      },
      "¬A27": {
        "formal": "¬A27",
        "prover9": "-A27",
        "prover9_expression": "-faces_termination(staff_member)",
        "natural": "The staff member does not face termination."
      },
      "¬A32": {
        "formal": "¬A32",
        "prover9": "-A32",
        "prover9_expression": "-meets_endpoint_criteria(trial)",
        "natural": "The trial does not meet endpoint criteria."
      },
      "¬A33": {
        "formal": "¬A33",
        "prover9": "-A33",
        "prover9_expression": "-shows_statistical_significance(trial)",
        "natural": "The trial does not show statistical significance."
      },
      "¬A36": {
        "formal": "¬A36",
        "prover9": "-A36",
        "prover9_expression": "-triggers_investigation(data_auditor)",
        "natural": "The data auditor does not trigger an investigation."
      },
      "¬A37": {
        "formal": "¬A37",
        "prover9": "-A37",
        "prover9_expression": "-passes_quality_control(drug)",
        "natural": "The drug does not pass quality control."
      },
      "¬A4": {
        "formal": "¬A4",
        "prover9": "-A4",
        "prover9_expression": "-receives_approval(fda, trial)",
        "natural": "The FDA does not receive approval for the trial."
      },
      "¬A41": {
        "formal": "¬A41",
        "prover9": "-A41",
        "prover9_expression": "-drops_out(patient)",
        "natural": "The patient does not drop out."
      },
      "¬A49": {
        "formal": "¬A49",
        "prover9": "-A49",
        "prover9_expression": "-launches_drug(company)",
        "natural": "The company does not launch the drug."
      },
      "¬A50": {
        "formal": "¬A50",
        "prover9": "-A50",
        "prover9_expression": "-generates_revenue(drug)",
        "natural": "The drug does not generate revenue."
      },
      "¬A8": {
        "formal": "¬A8",
        "prover9": "-A8",
        "prover9_expression": "-completes_trial(patient)",
        "natural": "The patient does not complete the trial."
      }
    }
  }
}